Kedarcidin Chromophore: an Enediyne That Cleaves DNA in a Sequence-Specific Manner N

Total Page:16

File Type:pdf, Size:1020Kb

Kedarcidin Chromophore: an Enediyne That Cleaves DNA in a Sequence-Specific Manner N Proc. Natl. Acad. Sci. USA Vol. 90, pp. 2822-2826, April 1993 Biochemistry Kedarcidin chromophore: An enediyne that cleaves DNA in a sequence-specific manner N. ZEIN*t, K. L. COLSONt, J. E. LEET*, D. R. SCHROEDERt, W. SOLOMON*, T. W. DOYLEt, AND A. M. CASAZZA* *Cancer Drug Discovery, Molecular Drug Mechanism, Pharmaceutical Research Institute, Bristol-Myers Squibb, P.O. Box 4000, Princeton, NJ 08543-4000; and *Chemistry and Analytical Research Division, Bristol-Myers Squibb, P.O. Box 5100, Wallingord, CT 06492-7660 Communicated by Donald M. Crothers, December 24, 1992 (receivedfor review November 9, 1992) ABSTRACT Kedarcidin chromophore is a 9-membered ence of CaCl2 implicate the 2-hydroxynaphthoyl moiety of enediyne, recentiy isolated from an actinomycete strain. In vivo the kedarcidin chromophore in the binding to the DNA. studies show this molecule to be extremely active against P388 leukemia and B16 melanoma. Cytotoxicity assays on the MATERIALS AND METHODS HCT116 colon carcinoma cell line result in an IC50 value of 1 nM. In vitro experiments with 4X174, pM2 DNA, and 32p- Chemicals. Kedarcidin chromophore and esperamicin A1, end-labeled restriction fragments demonstrate that this chro- prepared as described (3, 7), were obtained from the Division mophore binds and cleaves duplex DNA with a remarkable of Chemistry, Bristol-Myers Squibb (Wallingford, CT). The sequence selectivity producing single-strand breaks. The cleav- DNA plasmids [¢X174 replicative form I (RFI), replicative age chemistry requires reducing agents and oxygen similar to form II (RFII), and + strand; pM2; pBR322; and pUC18], the the other naturally occurring enediynes. Certain cations (Ca2+ restriction enzymes, and the Klenow fragment of DNA and Mg2+) prevent strand cleavage. High-resolution 'H NMR polymerase I were purchased from Boehringer Mannheim, studies on the chromophore in the presence ofcalcium chloride New England Biolabs, and GIBCO/BRL. The salmon sperm ihplicate the 2-hydroxynaphthoyl moiety in DNA binding. DNA was purchased from Sigma, sonicated, and ethanol- Interestingly, the kedarcidin chromophore appears structur- precipitated prior to use. Netropsin and calicheamicin 'I ally related to neocarzinostatin yet recognizes specific DNA were a gift from Lederle Laboratories (Pearl River, NY). The sequences in a manner similar to calicheamicin 'A, an enediyne radiochemicals were purchased from New England Nuclear/ with a signicantly different structure. Moreover, kedarcidin DuPont. and calicheamicin share a DNA preferred site, the TCCTN- Preparation of Linearized (Form Im) 4X174. Linearized mer. These observations indicate that the individual structural (X174 DNA (form III) was obtained by cleaving the cova- features ofthese agents are not solely responsible for their DNA lently closed circular RFI DNA with the restriction enzyme selectivity. Rather, a complementarity between their overall Pst I. The digest was phenol-extracted and washed with tertiary structure and the local conformation of the DNA at the chloroform prior to ethanol precipitation and washing. The binding sites must play a significant role in the recognition DNA was quantitated by UV spectroscopy. process. Determination ofSingle-Strand vs. Double-Strand Cleavage. The chromophore (1 ,ul of a 10x solution; see Fig. 1) was The DNA binding and cleavage properties of the potent incubated with 0.16 ,g of pure covalently closed circular enediyne antitumor antibiotics have been the focus ofintense (form I) pM2 DNA and 14 mM 2-mercaptoethanol in dimethyl study by a number of groups for the past several years. sulfoxide (DMSO)/35 mM Tris'HCl, pH 7.5, 10:90 (vol/vol), Kedarcidin chromoprotein is a recently identified member of (DMSO/Tris) at 370C for various lengths of time, in a total this unusual family of microbial metabolites (1-3, t). In vitro reaction volume of 10 ,ul. When required, hydrazine and cytotoxicity assays using the HCT116 colon carcinoma cell putrescine were added, each to 100 mM (final concentration), line showed the chromophore to possess potent cytotoxicity and the reaction mixture was incubated at 37°C for an (IC50, 1 nM) similar to that of Adriamycin (W.S. and N.Z., additional hour (21). The different forms of DNA were unpublished data). Moreover, the chromophore exhibited separated on a 0.9% agarose gel after a 15-h electrophoresis superior antitumor activity against murine P388 leukemia and at 30 V with subsequent ethidium bromide staining. The B16 melanoma models (W. C. Rose, personal communica- stained gels were photographed and the intensity ofthe DNA tion). As with neocarzinostatin (4-7), kedarcidin chro- bands was assessed by linear scanning microdensitometry mophore, a labile 9-membered enediyne, occurs as a com- (22). ponent of a highly acidic chromoprotein (1-3). This is in Comparison of the Cleavage of Different 4X174 Forms by contrast to esperamicin, calicheamicin, and dynemicin, the Chromophore. All four forms (+ strand, RFI, RFII, and agents that contain 10-membered enediyne rings and, to date, RFIII) of 4X174 DNA were incubated overnight with the have been isolated without associated apoproteins (8-11). In chromophore as described above. this paper, we report that the kedarcidin chromophore inter- Preparation and Labeling of Restriction Fragments. Five acts with duplex DNA and produces specific single-strand restriction fragments were isolated and 5'-end-labeled by cuts. The cleavage chemistry requires reducing agents and using [y-32P]dATP and polynucleotide kinase. The fragments oxygen similar to the other naturally occurring enediynes were a 275-bp pBR322 Sal I-BamHI fragment, a 159-bp (4-7, 12-20). Interestingly, in contrast to calicheamicin and pBR322 HindIII-EcoRV fragment, a 159-bp pBR322 EcoRV- esperamicin, the addition of divalent cations, such as Ca2+ and Mg2+, inhibits DNA cleavage by the kedarcidin chro- Abbreviations: RF, replicative form; DMSO, dimethyl sulfoxide. mophore. High-resolution 1H NMR experiments in the pres- tTo whom reprint requests should be addressed. tCroswell, A. R., Rose, W. C., Clark, J. L., Johnston, K. A., MacBeth, J. L., Matson, J. A., Hofstead, S. J., Lam, K. S., Long, The publication costs of this article were defrayed in part by page charge B. L., Schurig, J. E. & Casazza, A. M., 81st Annual Meeting ofthe payment. This article must therefore be hereby marked "advertisement" American Association for Cancer Research, May 23-26, 1990, in accordance with 18 U.S.C. §1734 solely to indicate this fact. Washington, DC, Vol. 31, p. 416, abstr. 2468. 2822 Downloaded by guest on September 23, 2021 Biochemistry: Zein et al. Proc. Natl. Acad. Sci. USA 90 (1993) 2823 HA-- CH30 I H3C H,C Esperamicin Al CH X 3 0 OH CHO 0 \ o H3CAj jH3 OH Neocarzinostatin Kedarcidin Kedarcidin chromophore chromophore chromophore with Ca2+ HindIII fragment, a 180-bp pUC18 EcoRI-Pvu II fragment, Netropsin Competition Experiments. The DNA was treated and a 140-bp pUC18 EcoRI-Pvu II fragment. Two of these with netropsin at 50 ,g/ml in presence of 2-mercaptoethanol fragments, the 275-bp pBR322 Sal I-BamHI fragment and the for 15 min in DMSO/Tris. The solution was then lyophilized, 159-bp pBR322 HindIII-EcoRV fragment, were also 3'-end- redissolved in buffer, and treated as described above with labeled using the Klenow fragment methodology with kedarcidin chromophore. [a-32P]dCTP (22). High-Resolution Proton 'H NMR Experiments. Two identical Cleavage Specificity with 5'- and 3'-End-Labeled Restriction NMR samples of 3.6 mM kedarcidin in [2H]DMSO were Fragments. The compound (1 ,l of a 1Ox solution) was prepared. To one sample, increasing amounts of a solution of incubated with carrier salmon sperm DNA at 5 ,g/ml and CaCl2 in 2H20 were added to achieve concentrations of0 mM, end-labeled DNA (-6000 cpm) in presence of 14 mM 2-mer- 8 mM, 16 mM, 58 mM, 125 mM, and 258 mM. To the control captoethanol in a total volume of 10 ,lI. The reactions were sample, equivalent amounts of 2H20 were added to account carried out at 37°C for 15 h in DMSO/Tris, lyophilized, for dilution effects. NMR spectra of both samples were dissolved in denaturing loading dye, and analyzed on a 12% obtained at each concentration at 500.13 MHz on a Bruker polyacrylamide sequencing gel at 1200 V for 3 h. Cleavage AM-500 equipped with a 5-mm broad-banded probe. Each sites were deduced by comparison to the Maxam-Gilbert spectrum was acquired using 32,000 data points, 128 scans, chemical sequencing lanes (G, AG, C, and TC) (22, 23). and a 450 observation pulse. Exponential multiplication with a Cleavage Under Anaerobic Conditions. The reaction con- line broadening of0.1 Hz was used in data processing. Spectra ditions were identical to those described earlier except that were referenced to the solvent ([2H]DMSO, "100%o deuterat- the final reaction volume was in this case 50 ,.dL The solution ed"; MSD Isotopes) at 2.49 ppm. was deaerated several times prior to the addition of drug and 2-mercaptoethanol to the reaction mixture, by using argon RESULTS and a Firestone valve. The incubation was carried out under In Vitro Single-Strand Cleavage. Incubation of the kedar- a positive pressure of argon. cidin chromophore at 37°C with form I pM2 DNA in presence Cleavage in the Presence of Salts, Superoxide Dismutase, of 14 mM 2-mercaptoethanol overnight resulted in the con- and Catalase. When the cleavage was performed in presence version of form I DNA to mostly open circular DNA (form of salts, identical conditions to those mentioned above were II). Some double-strand breaks (form III) were observed at carried except for the addition of 1 Al of a 10x solution of higher concentrations. A plot of the consumption of form I CaC12, NaCl, MgCl2, superoxide dismutase, and catalase (see and the formation of forms II and III as a function of drug Fig. 3). concentration is shown in Fig.
Recommended publications
  • C-1027, a Radiomimetic Enediyne Anticancer Drug, Preferentially Targets Hypoxic Cells
    Research Article C-1027, A Radiomimetic Enediyne Anticancer Drug, Preferentially Targets Hypoxic Cells Terry A. Beerman,1 Loretta S. Gawron,1 Seulkih Shin,1 Ben Shen,2 and Mary M. McHugh1 1Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York;and 2Division of Pharmaceutical Sciences, University of Wisconsin National Cooperative Drug Discovery Group, and Department of Chemistry, University of Wisconsin, Madison, Wisconsin Abstract identified primarily from studies with neocarzinostatin (NCS), a The hypoxic nature of cells within solid tumors limits the holo-form drug, consisting of an apoprotein carrier and an active efficacy of anticancer therapies such as ionizing radiation and chromophore, and was assumed to be representative of all agents conventional radiomimetics because their mechanisms re- in this class (11). The NCS chromophore contains a bicyclic quire oxygen to induce lethal DNA breaks. For example, the enediyne that damages DNA via a Myers-Saito cycloaromatization conventional radiomimetic enediyne neocarzinostatin is 4- reaction, resulting in a 2,6-indacene diradical structure capable of fold less cytotoxic to cells maintained in low oxygen (hypoxic) hydrogen abstractions from deoxyribose (12, 13). Subsequent to compared with normoxic conditions. By contrast, the ene- generation of a sugar radical, reaction with oxygen quickly and diyne C-1027 was nearly 3-fold more cytotoxic to hypoxic than efficiently leads to formation of hydroxyl radicals that induce to normoxic cells. Like other radiomimetics, C-1027 induced DSBs/SSBs at a 1:5 ratio. The more recently discovered holo-form DNA breaks to a lesser extent in cell-free, or cellular hypoxic, enediyne C-1027 (Fig.
    [Show full text]
  • Enediynes, Enyneallenes, Their Reactions, and Beyond
    Advanced Review Enediynes, enyne-allenes, their reactions, and beyond Elfi Kraka∗ and Dieter Cremer Enediynes undergo a Bergman cyclization reaction to form the labile 1,4-didehy- drobenzene (p-benzyne) biradical. The energetics of this reaction and the related Schreiner–Pascal reaction as well as that of the Myers–Saito and Schmittel reac- tions of enyne-allenes are discussed on the basis of a variety of quantum chemical and available experimental results. The computational investigation of enediynes has been beneficial for both experimentalists and theoreticians because it has led to new synthetic challenges and new computational methodologies. The accurate description of biradicals has been one of the results of this mutual fertilization. Other results have been the computer-assisted drug design of new antitumor antibiotics based on the biological activity of natural enediynes, the investigation of hetero- and metallo-enediynes, the use of enediynes in chemical synthesis and C materials science, or an understanding of catalyzed enediyne reactions. " 2013 John Wiley & Sons, Ltd. How to cite this article: WIREs Comput Mol Sci 2013. doi: 10.1002/wcms.1174 INTRODUCTION symmetry-allowed pericyclic reactions, (ii) aromatic- ity as a driving force for chemical reactions, and (iii) review on the enediynes is necessarily an ac- the investigation of labile intermediates with biradical count of intense and successful interdisciplinary A character. The henceforth called Bergman cyclization interactions of very different fields in chemistry provided deeper insight into the electronic structure involving among others organic chemistry, matrix of biradical intermediates, the mechanism of organic isolation spectroscopy, quantum chemistry, biochem- reactions, and orbital symmetry rules.
    [Show full text]
  • Inotuzumab Ozogamicin Is an Investigational Agent and Has Not Been Approved for Marketing by Any Regulatory Agency at This Time
    Inotuzumab Ozogamicin is an investigational agent and has not been approved for marketing by any regulatory agency at this time. ABOUT INOTUZUMAB OZOGAMICIN Inotuzumab ozogamicin is an investigational antibody-drug conjugate (ADC) comprised of a monoclonal antibody (mAb) targeting CD22, a cell surface antigen found on cancer cells in almost all B-ALL patients, linked to a cytotoxic agent.1,2 When inotuzumab ozogamicin binds to the CD22 antigen on B-cells, it is internalized into the cell, where the cytotoxic agent calicheamicin is released to destroy the cell.3 ABOUT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) Acute lymphoblastic leukemia (ALL) in adults is an aggressive leukemia that can be fatal within a matter of months if left untreated.4 While many potential treatments have been studied, only a limited number of medicines for relapsed or refractory adults with ALL have been approved by the FDA and other regulatory authorities in the past decade. The current standard treatment is intensive, lengthy chemotherapy with the goal of halting the signs and symptoms of ALL (called hematologic remission) and patients becoming eligible for a stem cell transplant.4 UNMET NEEDS IN ADULT ALL Statistics & Patient Characteristics Statistics & Patient Characteristics • In 2017, it is estimated that 5,970 cases of ALL • Approximately half of U.S. adults who learn they will be diagnosed in the United States, with about have ALL this year will not respond to commonly 4 in 10 cases occurring in adults.5 used chemotherapy agents (e.g., be refractory) or will eventually see their disease return (e.g., relapse).5 • While significant strides have been made in treating children with ALL, the opposite is true for adults with • The outlook for adults with relapsed or refractory the disease.
    [Show full text]
  • WO 2018/067991 Al 12 April 2018 (12.04.2018) W !P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/067991 Al 12 April 2018 (12.04.2018) W !P O PCT (51) International Patent Classification: achusetts 021 15 (US). THE BROAD INSTITUTE, A61K 51/10 (2006.01) G01N 33/574 (2006.01) INC. [US/US]; 415 Main Street, Cambridge, Massachu C07K 14/705 (2006.01) A61K 47/68 (2017.01) setts 02142 (US). MASSACHUSETTS INSTITUTE OF G01N 33/53 (2006.01) TECHNOLOGY [US/US]; 77 Massachusetts Avenue, Cambridge, Massachusetts 02139 (US). (21) International Application Number: PCT/US2017/055625 (72) Inventors; and (71) Applicants: KUCHROO, Vijay K. [IN/US]; 30 Fairhaven (22) International Filing Date: Road, Newton, Massachusetts 02149 (US). ANDERSON, 06 October 2017 (06.10.2017) Ana Carrizosa [US/US]; 110 Cypress Street, Brookline, (25) Filing Language: English Massachusetts 02445 (US). MADI, Asaf [US/US]; c/o The Brigham and Women's Hospital, Inc., 75 Francis (26) Publication Language: English Street, Boston, Massachusetts 021 15 (US). CHIHARA, (30) Priority Data: Norio [US/US]; c/o The Brigham and Women's Hospital, 62/405,835 07 October 2016 (07.10.2016) US Inc., 75 Francis Street, Boston, Massachusetts 021 15 (US). REGEV, Aviv [US/US]; 15a Ellsworth Ave, Cambridge, (71) Applicants: THE BRIGHAM AND WOMEN'S HOSPI¬ Massachusetts 02139 (US). SINGER, Meromit [US/US]; TAL, INC. [US/US]; 75 Francis Street, Boston, Mass c/o The Broad Institute, Inc., 415 Main Street, Cambridge, (54) Title: MODULATION OF NOVEL IMMUNE CHECKPOINT TARGETS CD4 FIG.
    [Show full text]
  • Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin
    CCR FOCUS Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin Alejandro D. Ricart Abstract Antibody-drug conjugates (ADC) are an attractive approach for the treatment of acute myeloid leukemia and non-Hodgkin lymphomas, which in most cases, are inherently sensitive to cytotoxic agents. CD33 and CD22 are specific markers of myeloid leukemias and B-cell malignancies, respectively. These endocytic receptors are ideal for an ADC strategy because they can effectively carry the cytotoxic payload into the cell. Gemtuzumab ozogamicin (GO, Mylotarg) and inotuzumab ozogamicin consist of a derivative of calichea- micin (a potent DNA-binding cytotoxic antibiotic) linked to a humanized monoclonal IgG4 antibody directed against CD33 or CD22, respectively. Both of these ADCs have a target-mediated pharmacokinetic disposition. GO was the first drug to prove the ADC concept in the clinic, specifically in phase II studies that included substantial proportions of older patients with relapsed acute myeloid leukemia. In contrast, in phase III studies, it has thus far failed to show clinical benefit in first-line treatment in combination with standard chemotherapy. Inotuzumab ozogamicin has shown remarkable clinical activity in relapsed/refractory B-cell non-Hodgkin lymphoma, and it has started phase III evaluation. The safety profile of these ADCs includes reversible myelosuppression (especially neutropenia and thrombocyto- penia), elevated hepatic transaminases, and hyperbilirubinemia. There have been postmarketing reports of hepatotoxicity, especially veno-occlusive disease, associated with GO. The incidence is 2%, but patients who undergo hematopoietic stem cell transplantation have an increased risk. As we steadily move toward the goal of personalized medicine, these kinds of agents will provide a unique opportunity to treat selected patient subpopulations based on the expression of their specific tumor targets.
    [Show full text]
  • Design, Synthesis and Reactivity of Cyclopropenone
    DESIGN, SYNTHESIS AND REACTIVITY OF CYCLOPROPENONE- CONTAINING NINE MEMBERED CYCLIC ENEDIYNE AND ENYNE-ALLENE PRECURSORS AS PROTOTYPE PHOTOSWITCHABLE ANTITUMOR AGENTS by DINESH R. PANDITHAVIDANA (Under the Direction of Vladimir V. Popik) ABSTRACT The extreme cytotoxicity of natural enediyne antibiotics is attributed to the ability of the ( Z)-3-hexene-1,5-diyne (enediyne) and ( Z)-1,2,4-heptatrien-6-yne (enyne–allene) fragments incorporated into a 10- or 9-membered ring cyclic system to undergo cycloaromatization producing dDNA-damaging 1,4-diradicals. The rate of cyclization of enediynes to p-benzynes strongly depends on the distance between acetylenic termini, which in turn can be controlled by the ring size. Thus, 11-membered ring enediynes are stable, 10-membered ring analogs undergo slow cycloaromatization under ambient conditions or mild heating, 9- membered ring enediynes are virtually unknown and believed to undergo very fast spontaneous cyclization. Cyclic enyne-allenes have not been synthesized so far due to very facile Myers-Saito cyclization. We have developed thermally stable photo-precursors of 9-membered enediynes ( 2.22 , 2.26 ) and enyne-allene ( 2.44 ), in which one of the triple bonds is replaced by the cyclopropenone group. UV irradiation of 2.14 results in the efficient decarbonylation (Φ 254 = 0.34) and the formation of reactive enediyne 2.22. The latter undergoes clean cycloaromatization to 2,3-dihydro-1H- cyclopenta[b]naphthalen-1-ol ( 2.24 ) with a life-time of ca. 2 h in 2-propanol at 25 °C. The rate of this reaction depends linearly on the concentration of hydrogen donor and shows a primary kinetic isotope effect in 2-propanol-d8.
    [Show full text]
  • Molecular Biosystems
    Molecular BioSystems View Article Online PAPER View Journal | View Issue Cloning and sequencing of the kedarcidin biosynthetic Cite this: Mol. BioSyst., 2013, gene cluster from Streptoalloteichus sp. ATCC 53650 9, 478 revealing new insights into biosynthesis of the enediyne family of antitumor antibiotics† Jeremy R. Lohman,a Sheng-Xiong Huang,a Geoffrey P. Horsman,b Paul E. Dilfer,a Tingting Huang,a Yihua Chen,b Evelyn Wendt-Pienkowskib and Ben Shenz*abcd Enediyne natural product biosynthesis is characterized by a convergence of multiple pathways, generating unique peripheral moieties that are appended onto the distinctive enediyne core. Kedarcidin (KED) possesses two unique peripheral moieties, a (R)-2-aza-3-chloro-b-tyrosine and an iso- propoxy-bearing 2-naphthonate moiety, as well as two deoxysugars. The appendage pattern of these peripheral moieties to the enediyne core in KED differs from the other enediynes studied to date with respect to stereochemical configuration. To investigate the biosynthesis of these moieties and expand our understanding of enediyne core formation, the biosynthetic gene cluster for KED was cloned from Streptoalloteichus sp. ATCC 53650 and sequenced. Bioinformatics analysis of the ked cluster revealed the presence of the conserved genes encoding for enediyne core biosynthesis, type I and type II polyketide synthase loci likely responsible for 2-aza-L-tyrosine and 3,6,8-trihydroxy-2-naphthonate Received 16th November 2012, formation, and enzymes known for deoxysugar biosynthesis. Genes homologous to those responsible Accepted 20th January 2013 for the biosynthesis, activation, and coupling of the L-tyrosine-derived moieties from C-1027 and DOI: 10.1039/c3mb25523a maduropeptin and of the naphthonate moiety from neocarzinostatin are present in the ked cluster, supporting 2-aza-L-tyrosine and 3,6,8-trihydroxy-2-naphthoic acid as precursors, respectively, for the www.rsc.org/molecularbiosystems (R)-2-aza-3-chloro-b-tyrosine and the 2-naphthonate moieties in KED biosynthesis.
    [Show full text]
  • Probing Interaction Motifs for Ligand Binding Prediction from Three
    PROBING INTERACTION MOTIFS FOR LIGAND BINDING PREDICTION FROM THREE PERSPECTIVES: ASSESSING PROTEIN SIMILARITY, LIGAND SIMILARITY AND COMPONENTS OF PROTEIN-LIGAND INTERACTIONS By Nan Liu A DISSERTATION Submitted to Michigan State University in partial fulfillment of the requirements for the degree of Chemistry – Doctor of Philosophy 2015 ABSTRACT PROBING INTERACTION MOTIFS FOR LIGAND BINDING PREDICTION FROM THREE PERSPECTIVES: ASSESSING PROTEIN SIMILARITY, LIGAND SIMILARITY AND COMPONENTS OF PROTEIN-LIGAND INTERACTIONS By Nan Liu The interactions between small molecules and diverse enzyme, membrane receptor and channel proteins are associated with important biological processes and diseases. This makes the study of binding motifs between proteins and ligands appealing to scientists. We use multiple computational techniques to unveil the protein-ligand interaction motifs from three perspectives. Firstly, from the perspective of proteins, by comparing the structure differences and common features of different binding sites for the same ligand, 3-dimensional motifs that represent the favorable interactions of the same ligands can be extracted. The goal is for such a motif to represent the shared features for binding a certain ligand in unrelated proteins, while discriminating from other ligands. The 3-dimensional motifs for cholesterol and cholate binding to non-homologous protein sites have been extracted, using SimSite3D alignment and analysis of the conserved interactions between these sites. The 3-dimensional protein motif for cholesterol binding can give about 80% accuracy of true positive sites with a low false positive rate. Furthermore, an online server CholMine was established so that the users can use this approach to predict cholesterol and cholate binding sites in proteins of interest.
    [Show full text]
  • The Novel Calicheamicin-Conjugated CD22 Antibody Inotuzumab Ozogamicin (CMC-544) Effectively Kills Primary Pediatric Acute Lymphoblastic Leukemia Cells
    Leukemia (2012) 26, 255–264 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu ORIGINAL ARTICLE The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells JF de Vries1, CM Zwaan2, M De Bie1, JSA Voerman1, ML den Boer2, JJM van Dongen1 and VHJ van der Velden1 1Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands and 2Department of Pediatric Oncology/Hematology, Erasmus MC, Sophia Children’s Hospital, Rotterdam, The Netherlands We investigated whether the newly developed antibody (Ab) - One of these new approaches is antibody (Ab)-targeted targeted therapy inotuzumab ozogamicin (CMC-544), consisting chemotherapy, where the Ab-part of the compound is used to of a humanized CD22 Ab linked to calicheamicin, is effective in specifically deliver the cytostatic drug to the target cell, resulting pediatric primary B-cell precursor acute lymphoblastic leuke- mia (BCP-ALL) cells in vitro, and analyzed which parameters in less or no bystander cell death. One of the first examples of Ab- determine its efficacy. CMC-544 induced dose-dependent cell based delivery is gemtuzumab ozogamicin (GO, Mylotarg kill in the majority of BCP-ALL cells, although IC50 values varied or CMA-676), which consists of a humanized CD33 Ab substantially (median 4.8 ng/ml, range 0.1–1000 ng/ml at 48 h). covalently linked to a derivative of the potent DNA-damaging The efficacy of CMC-544 was highly dependent on calicheami- cytotoxic agent calicheamicin.7,8 Calicheamicin induces cell cin sensitivity and CD22/CMC-544 internalization capacity of BCP-ALL cells, but hardly on basal and renewed CD22 death in its target cells by interaction with double-helical DNA in expression.
    [Show full text]
  • Selective Proteolytic Activity of the Antitumor Agent Kedarcidin N
    Proc. Natl. Acad. Sci. USA Vol. 90, pp. 8009-8012, September 1993 Biochemistry Selective proteolytic activity of the antitumor agent kedarcidin N. ZEIN*t, A. M. CASAZZA*, T. W. DOYLE*, J. E. LEETt, D. R. SCHROEDERt, W. SOLOMON*, AND S. G. NADLER§ *Cancer Drug Discovery, Molecular Drug Mechanism, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 4000, Princeton, NJ 08543-4000; tChemistry Division, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5100, Wallingford, CT 06492-7660; and §Antitumor Immunology, Bristol-Myers Squibb Pharmaceutical Research Institute, 3005 1st Avenue, Seattle, WA 98121 Communicated by William P. Jencks, May 27, 1993 ABSTRACT Kedarcidin is a potent antitumor antibiotic there is substantial in vitro chemical and structural informa- chromoprotein, composed of an enediyne-containing chro- tion (4-21). Furthermore, it was proposed that the neocarzi- mophore embedded in a highly acidic single chain polypeptide. nostatin apoprotein stabilizes and regulates the availability of The chromophore was shown to cleave duplex DNA site- the labile chromophore (4-9). As previously shown for specifically in a single-stranded manner. Herein, we report that neocarzinostatin (4-9), DNA experiments with the isolated in vitro, the kedarcidin apoprotein, which lacks any detectable chromophore and the kedarcidin chromoprotein demon- chromophore, cleaves proteins selectively. Histones that are the strated that DNA cleavage was mostly due to the chro- most opposite in net charge to the apoprotein are cleaved most mophore (N.Z. and W.S., unpublished data). However, readily. Our findings imply that the potency of kedarcidin cytotoxicity assays using human colon cancer cell lines HCT results from the combination of a DNA damaging-chro- 116 showed the chromophore and the chromoprotein to mophore and a protease-like apoprotein.
    [Show full text]
  • Total Synthesis of Calicheamicin Type Enediyne Natural Products
    Total Synthesis of Calicheamicin Type Enediyne Natural Products 17/09/02 Yuki Fujimoto 1 Contents 2 Enediyne Natural Products SSS Me O OMe NHCO 2Me MeO O O H OH HO O N O O O OMe S O OH HO I OH O OMe O NHEt I calicheamicin 1 (calicheamicin type) OMe O O O O CO 2H OH O HN O O OMe OH O O MeH N HO OH O OH O OH dynemicin A (dynemicin type) neocarzinostatin chromophore (chromoprotein type) 3 Bergman Cyclization Jones, R. R.; Bergman, R. G . J. Am. Chem. Soc. 1972 , 94 , 660. 4 Distance of Diyne a) Nicolaou, K. C.; Zuccarello, G.; Ogawa, Y.; Schweiger, E. J.; Kumazawa, T. J. Am. Chem. Soc. 1988 , 110 , 4866. 5 b) Nicolaou, K. C.; Dai, W. M. Angew. Chem. Int. Ed. Engl. 1991 , 30 , 1387. Calicheamicin Type Action Mechanism Nicolaou, K. C.; Dai, W. M. Angew. Chem. Int. Ed. Engl. 1991 , 30 , 1387 6 Contents 7 Introduction of Calicheamicin SSS Me O OMe NHCO 2Me MeO O O H OH HO O N O O O OMe S O OH HO I OH O OMe NHEt I O calicheamicin 1 SSS Me Isolation O 1) NHCO 2Me bacterial strain Micromonospora echinospora ssp calichensis I Total synthesis of calicheamicin 1 HO OH Nicolaou, K. C. (1992, enantiomeric) 2) Danishefsky (1994, enantiomeric) 3) Total synthesis of calicheamicinone Danishefsky, S. J. (1990, racemic) 4) Nicolaou, K. C. (1993, enantiomeric) 5) calicheamicinone Clive, D. L. J. (1996, racemic) 6) (calicheamicin aglycon) Magnus, P. (1998, racemic) 7) 1) Borders, D.
    [Show full text]
  • Precursor-Directed Biosynthesis of Azinomycin a and Related Metabolites by Streptomyces Sahachi- Roi
    ORBIT-OnlineRepository ofBirkbeckInstitutionalTheses Enabling Open Access to Birkbeck’s Research Degree output Precursor-Directed Biosynthesis of Azinomycin A and Related Metabolites by Streptomyces sahachi- roi https://eprints.bbk.ac.uk/id/eprint/40052/ Version: Full Version Citation: Sebbar, Abdel-Ilah (2014) Precursor-Directed Biosynthesis of Azinomycin A and Related Metabolites by Streptomyces sahachiroi. [Thesis] (Unpublished) c 2020 The Author(s) All material available through ORBIT is protected by intellectual property law, including copy- right law. Any use made of the contents should comply with the relevant law. Deposit Guide Contact: email Precursor-Directed Biosynthesis of Azinomycin A and Related Metabolites by Streptomyces sahachiroi Abdel-Ilah Sebbar Department of Biological Sciences School of Science Birkbeck College University of London A thesis submitted to the University of London for the degree of Doctor of Philosophy August 2014 Declaration The work presented in this thesis in entirely on my own, except where I have either acknowledged help from a known person or given a published reference. 15/8/14 Signed: ………………. Date:… ………………... PhD student: Abdel-Ilah Sebbar Department of Biological Sciences School of Science Birkbeck College University of London 15/8/14 Signed: Date: …………………... Supervisor: Dr. Philip Lowden Department of Biological Sciences School of Science Birkbeck College University of London 2 Abstract Azinomycins A and B are bioactive compounds produced by Streptomyces species. These naturally occurring antibiotics exhibit potent in vitro cytotoxic activity, promising in vivo antitumor activity and exert their effect by disruption of DNA replication by the formation of interstrand cross-links. The electrophilic C-10 and C-21 carbons contained within the aziridine and epoxide moieties are known to be responsible for the interstrand cross-links through alkylation of N-7 atoms of guanine bases.
    [Show full text]